PathAI Expands PathExplore Reach to 14 Cancer Types

PathAI Expands PathExplore Reach to 14 Cancer Types

PathAI, a pioneer in AI-powered pathology, announced a significant expansion of its PathExplore platform, adding six new oncology indications

Read on

Medigy Insights

PathAI, a leader in AI-powered pathology, has expanded its PathExplore platform by adding six new oncology indications, doubling its coverage to 14 cancer types. PathExplore focuses on characterizing the tumor microenvironment (TME) from H&E-stained whole-slide images, addressing challenges in capturing the full resolution and spatial intricacies of the TME. The platform leverages AI to analyze these images, providing researchers with a detailed understanding of cell types, tissue structures, and spatial relationships in the TME. The expansion includes ovarian, bladder, liver, small cell lung, lymphoma, and head and neck cancers, enabling a broader exploration of the TME for new insights and personalized treatment options. PathExplore has become a trusted ally in cancer research, with over 50 partnerships and contributions to 50 publications and presentations. The platform aims to revolutionize cancer research and treatment by unlocking the secrets of the TME and providing actionable insights for precision oncology.

Deploy this technology today

Next Article

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.

© 2024 Netspective Media LLC. All Rights Reserved.

Built on Feb 23, 2024 at 3:55am